NM_173689.7:c.2277G>A
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_173689.7(CRB2):c.2277G>A(p.Trp759*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000757 in 1,612,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_173689.7 stop_gained
Scores
Clinical Significance
Conservation
Publications
- focal segmental glomerulosclerosis 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- ventriculomegaly-cystic kidney diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CRB2 | ENST00000373631.8 | c.2277G>A | p.Trp759* | stop_gained | Exon 8 of 13 | 1 | NM_173689.7 | ENSP00000362734.3 | ||
| CRB2 | ENST00000359999.7 | c.2277G>A | p.Trp759* | stop_gained | Exon 8 of 10 | 2 | ENSP00000353092.3 | |||
| CRB2 | ENST00000460253.1 | n.1281G>A | non_coding_transcript_exon_variant | Exon 3 of 9 | 2 | ENSP00000435279.1 | 
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152190Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.00000802  AC: 2AN: 249304 AF XY:  0.00000741   show subpopulations 
GnomAD4 exome  AF:  0.0000822  AC: 120AN: 1460090Hom.:  0  Cov.: 35 AF XY:  0.0000799  AC XY: 58AN XY: 726346 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152190Hom.:  0  Cov.: 33 AF XY:  0.0000269  AC XY: 2AN XY: 74346 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Pathogenic:2 
For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with clinical features of focal segmental glomerulosclerosis (PMID: 25557780). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 180704). This variant is present in population databases (rs375072557, ExAC 0.003%). This sequence change creates a premature translational stop signal (p.Trp759*) in the CRB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CRB2 are known to be pathogenic (PMID: 27942854, 30212996). -
Observed with a second CRB2 variant on the opposite allele (in trans) in two sibling fetuses with renal microcysts and ventriculomegaly (Slavotinek et al., 2015); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28425981, 25557780, 36685964, 36549870) -
Ventriculomegaly-cystic kidney disease    Pathogenic:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at